食品サプリメントの規制とプロフェッショナル・プラクティスの薬剤師の責任:レビュー
Cristina Ioana Niculaș1, Sonia Bianca Blaj2, Marius Călin Cherecheș3
1Medicine and Pharmacy Doctoral School, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Targu Mures, 540142 Targu Mures, Romania.
Pharmacy (Basel, Switzerland)
|February 20, 2026
まとめ
世界的なサプリメント規制は一貫性がないため,薬剤師には課題が生じています. このレビューは,標準化された法律の欠如を強調し,消費者の安全性に関する懸念にもかかわらず,サプリメントの配給に関連する不正行為のケースを特定していません.
科学分野:
- 医薬品科学 医薬品科学とは
- 規制問題 規制問題
- 公衆衛生は公衆衛生である.
背景:
- 食品サプリメントに関する世界的な規制は,ある国で禁止された製品が他の国で合法的に販売されることを許可し,オンライン販売によって悪化させ,大きな変動を示しています.
- 医薬品の誤用に関する統一された欧州の枠組みの欠如は,薬剤師の責任の評価を複雑化し,代わりに個々の加盟国の法律によって規制されています.
研究 の 目的:
- 食品サプリメントの世界的な規制の状況をマッピングする.
- 食品サプリメントに関する薬剤師の職業的責任と不正行為のリスクを検証する.
主な方法:
- 2020年1月から2024年12月までの期間,Scopus,PubMed,Embase,Web of Scienceからの77件の研究を分析した包括的な文献レビューが行われました.
- 抽出したデータは,薬剤師の責任/誤用,サプリメント規制,消費者の安全性,健康に関する主張,および薬剤師の知識にテーマ別に分類されました.
主要な成果:
- 薬局における誤診のケースは比較的まれで,薬剤師が食品サプリメントを配給する責任に関与した症例は確認されていない.
- 食品サプリメントの規制には,標準化されていない用語,異なる市場アクセス要件,製品の組成とラベリングの不適合など,重大な矛盾がある.
- 広範囲にわたる誤解を招く広告と健康に関する主張に対する規制の違反が観察され,サプリメントの配給に関する薬剤師の知識に問題がある.
結論:
- 食品サプリメントに関する調和したグローバルな規制枠組みの欠如は,薬剤師の専門的な役割と責任に関して曖昧さを生み出しています.
- 食品補助食品規制の矛盾に対処し,薬剤師の知識の向上は,消費者安全と専門的な説明責任の確保に不可欠です.
関連する概念動画
01:25Drug Regulation
3.2K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
3.2K
01:03Drug Control Governance: Regulatory Bodies and Their Impact
594
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
594
01:19Pharmacovigilance
1.8K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.8K
01:26Pharmaceutical Poisoning: Potential Scenarios
22
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
22
01:26FDA Approved Drugs: Changes to Approved Drugs
289
Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
289
01:24Dosage Regimen: Individualization
221
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
221